TERT promoter mutations in thyroid cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• TERT promoter mutations (TERT-p mutations) are prevalent across various cancers, significantly influencing tumor progression.
• TERT activation by these mutations leads to telomere elongation, granting cancer cells unlimited proliferative potential.
• TERT also plays a role in enhancing tumor aggressiveness and advancing disease progression.

Approach:

• This review synthesizes recent research on TERT-p mutations and their functional and mechanistic roles.
• Focuses on the implications of TERT-p mutations in differentiated thyroid carcinoma.
• Highlights TERT-p mutations as a critical molecular marker for predicting tumor aggressiveness.

Key Points:

• TERT-p mutations are crucial for unlimited cell proliferation in tumors.
• In differentiated thyroid carcinoma, TERT-p mutations correlate strongly with high-risk clinicopathological features.
• TERT-p mutations serve as a superior molecular marker for assessing thyroid tumor aggressiveness and prognosis.

Conclusions:

• TERT promoter mutations are significant oncogenic drivers with broad implications in cancer.
• Their association with aggressive phenotypes and poor prognosis in differentiated thyroid carcinoma underscores their clinical relevance.
• Understanding the functional aspects of TERT-p mutations is vital for developing targeted therapeutic strategies.